Arrhythmogenic Right Ventricular Cardiomyopathy

Cardiovascular
1
Pipeline Programs
2
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Tenaya Therapeutics
Tenaya TherapeuticsSOUTH SAN FRANCISCO, CA
2 programs
1
TN-401Phase 11 trial
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated N/A1 trial
Active Trials
NCT06311708RecruitingEst. Jul 2030
NCT06228924RecruitingEst. Oct 2029
Rhythm Pharmaceuticals
1 program
ECGN/A1 trial
Active Trials
NCT04895540UnknownEst. May 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Tenaya TherapeuticsTN-401
Tenaya TherapeuticsNon-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated
Rhythm PharmaceuticalsECG

Clinical Trials (3)

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Start: Mar 2024Est. completion: Oct 2029
Phase 1Recruiting
NCT06311708Tenaya TherapeuticsNon-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated

Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Start: Jan 2023Est. completion: Jul 2030
N/ARecruiting

South Asian Arrhythmogenic Cardiomyopathy Registry

Start: Apr 2021Est. completion: May 2022
N/AUnknown

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials
2 companies competing in this space